The mission of the Bioinformatics Shared Resource (BISR) is to guarantee the availability of comprehensive bioinformatics expertise to Sidney Kimmel Comprehensive Cancer Center (SKCCC) members involved in molecular cancer research, with special emphasis on techniques that generate high dimensional data. The BISR achieves this by partially funding the effort for several PhD-level investigators and related staff. BISR faculty have extensive experience in all aspects of high-throughput biological data analysis and computational modeling of biological systems. A critical development during the next funding period will be the emergence of large data sets comprising multiple omics data, including genomics (SNPs, allelic variation maps from high-throughput sequencing), epigenomics (methylation an-ays, bi-sulfite high-throughput sequencing), transcriptomics (microarrays and RNA-seq), proteomics (MS-MS and arrays), and metabolomics (MS and NMR). These data will require integration through annotations, both through genome sequence and using proteomic-based integration. Computational modeling of this data will play an increasingly important role, as the data could overwhelm mathematical analysis approaches that lack a biologically motivated model to place the data in context Pathway, network, and cellular systems analysis is expected to play a growing role in data interpretation, with systems biology and computational modeling emerging as critical capabilities for the BISR. This Core has been assembled with the breadth in expertise necessary for these developments. Lay: The Bioinformatics Resource provides comprehensive bioinformatics expertise to Cancer Center members involved in molecular cancer research, with special emphasis on techniques that generate high dimensional data. The BISR has several PhD-level investigators with extensive experience in all aspects of high-throughput biological data analysis and computational modeling of biological systems, together with support staff.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
4P30CA006973-53
Application #
9061630
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2016-05-01
Budget End
2017-04-30
Support Year
53
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Johnson, Renee M; Fleming, Charles B; Cambron, Christopher et al. (2018) Race/Ethnicity Differences in Trends of Marijuana, Cigarette, and Alcohol Use Among 8th, 10th, and 12th Graders in Washington State, 2004-2016. Prev Sci :
Marrone, Kristen A; Zhou, Xian; Forde, Patrick M et al. (2018) A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy-Naïve Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer. Oncologist 23:859-865
Bar-Shir, Amnon; Alon, Lina; Korrer, Michael J et al. (2018) Quantification and tracking of genetically engineered dendritic cells for studying immunotherapy. Magn Reson Med 79:1010-1019
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Teply, Benjamin A; Wang, Hao; Luber, Brandon et al. (2018) Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study. Lancet Oncol 19:76-86
Dean, Lorraine T; Nicholas, Lauren Hersch (2018) Using Credit Scores to Understand Predictors and Consequences of Disease. Am J Public Health 108:1503-1505
Litvak, Anya; Batukbhai, Bhavina; Russell, Stuart D et al. (2018) Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer. Cancer 124:1904-1911
Kandala, Sri Kamal; Liapi, Eleni; Whitcomb, Louis L et al. (2018) Temperature-controlled power modulation compensates for heterogeneous nanoparticle distributions: a computational optimization analysis for magnetic hyperthermia. Int J Hyperthermia :1-15
Adler, B L; Pezhouh, M K; Kim, A et al. (2018) Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. J Intern Med 283:568-577
Anchoori, Ravi K; Jiang, Rosie; Peng, Shiwen et al. (2018) Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer. ACS Omega 3:11917-11929

Showing the most recent 10 out of 2393 publications